Obesity trials recruiting in Colorado

All Obesity trials nationally

Cities in Colorado

Recruiting trials in Colorado

• A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
  NCT07667803 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Arvada
• A Pilot Factorial Trial of an Integrated Lifestyle Intervention
  NCT06116435 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · Colorado: Aurora
• A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
  NCT06672549 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · Colorado: Colorado Springs
• A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
  NCT06717698 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Aurora
• A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
  NCT07564414 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Aurora
• A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
  NCT07567001 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Aurora, Denver, Golden
• A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
  NCT07282600 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Aurora
• A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
  NCT07369011 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Aurora
• A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
  NCT07153471 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Colorado Springs
• A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
  NCT07202884 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Female · Colorado: Lakewood
• A Study of Pitolisant in Patients With Prader-Willi Syndrome
  NCT06366464 · Phase: Phase 3 · Ages: 6 Years and older · Sex: All (male and female) · Colorado: Aurora
• A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
  NCT06760546 · Phase: Phase 3 · Ages: 4 Years and older · Sex: All (male and female) · Colorado: Aurora
• Adipocyte-Derived Extracellular Vesicles, Weight Loss, and Endothelial Function
  NCT06776081 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · Colorado: Boulder
• Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma
  NCT03762395 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Colorado: Aurora
• BfedBwell INSPIRE Pilot
  NCT07446595 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · Colorado: Aurora
• Bioenergetic Effects of Aging and Menopause (BEAM)
  NCT04043520 · Phase: Phase 4 · Ages: 40 Years to 65 Years · Sex: Female · Colorado: Aurora
• Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
  NCT05082519 · Phase: Phase 2 · Ages: 7 Years to 25 Years · Sex: All (male and female) · Colorado: Denver
• Cardiometabolic Consequences of the Loss of Ovarian Function
  NCT06264882 · Phase: Phase 4 · Ages: 20 Years to 45 Years · Sex: Female · Colorado: Aurora
• Convergent Mechanisms Underlying Reprometabolic Syndrome in Women
  NCT06686537 · Phase: Phase 2 · Ages: 18 Years to 38 Years · Sex: Female · Colorado: Aurora
• Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)
  NCT05935826 · Phase: Phase 3 · Ages: 13 Years to 18 Years · Sex: All (male and female) · Colorado: Aurora
• Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
  NCT06129110 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · Colorado: Aurora
• Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
  NCT07353931 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Colorado Springs
• Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
  NCT07284875 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Aurora
• Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
  NCT05732623 · Phase: Not specified · Ages: 18 Years to 49 Years · Sex: All (male and female) · Colorado: Denver
• Glucagon-Like Peptide-1 Receptor Agonist in ADPKD
  NCT06582875 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Colorado: Aurora
• HealthyTogether: RCT of a Dyadic Weight Management Intervention
  NCT06619041 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Aurora
• International Weight Control Registry
  NCT04907396 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Denver
• Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity
  NCT05107908 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · Colorado: Aurora
• Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics
  NCT03215836 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · Colorado: Aurora
• Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents
  NCT06575738 · Phase: Phase 1 · Ages: 12 Years to 24 Years · Sex: All (male and female) · Colorado: Aurora
• Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
  NCT05008276 · Phase: Not specified · Ages: 8 Years to 14 Years · Sex: All (male and female) · Colorado: Aurora
• Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes
  NCT04791371 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years to 55 Years · Sex: All (male and female) · Colorado: Aurora
• Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome
  NCT05819853 · Phase: Phase 3 · Ages: 12 Years to 35 Years · Sex: Female · Colorado: Aurora
• Snacking Effects on the Brain Response to Foods and Satiety During Dieting
  NCT07428187 · Phase: Not applicable (e.g. observational or device study) · Ages: 25 Years to 45 Years · Sex: All (male and female) · Colorado: Aurora
• Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
  NCT06554717 · Phase: Phase 2 · Ages: 50 Years to 80 Years · Sex: All (male and female) · Colorado: Aurora
• The Early and Late Contribution of Fasting and Postprandial Triglycerides on Newborn Subcutaneous and Intrahepatic Fat in Pregnancy
  NCT04394806 · Phase: Not specified · Ages: 0 Years to 39 Years · Sex: All (male and female) · Colorado: Aurora
• Thermogenenic Responses to Fasting and Overfeeding in Women
  NCT06610162 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: Female · Colorado: Aurora
• Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
  NCT06414096 · Phase: Phase 1 · Ages: 19 Years to 37 Years · Sex: Female · Colorado: Aurora